<!DOCTYPE html>
<html lang="zh-cn">
  <head><script src="/livereload.js?mindelay=10&amp;v=2&amp;port=1315&amp;path=livereload" data-no-instant defer></script>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
    
    <title>瑞德·霍夫曼为AI癌症研究初创公司募资2460万美元 | AI内参</title>
    <meta name="viewport" content="width=device-width,minimum-scale=1">
    <meta name="description" content="瑞德·霍夫曼为AI癌症研究初创公司募资2460万美元">
    <meta name="generator" content="Hugo 0.147.0">
    
    
    
      <meta name="robots" content="noindex, nofollow">
    
    <meta name="author" content="AI News Assistant">
    

    


<link rel="stylesheet" href="/ananke/css/main.min.css" >



<link rel="stylesheet" href="/css/social-share.css">



  
    <link rel="stylesheet" href="/css/custom.css">
  

  
    <link rel="stylesheet" href="/css/article-enhancements.css">
  

    

<script src="/js/social-share.js"></script>



    
      

    

    

    
      <link rel="canonical" href="http://localhost:1315/insights/2025-06-08-article-416/">
    

    <meta property="og:url" content="http://localhost:1315/insights/2025-06-08-article-416/">
  <meta property="og:site_name" content="AI内参">
  <meta property="og:title" content="瑞德·霍夫曼为AI癌症研究初创公司募资2460万美元">
  <meta property="og:description" content="瑞德·霍夫曼为AI癌症研究初创公司募资2460万美元">
  <meta property="og:locale" content="zh_cn">
  <meta property="og:type" content="article">
    <meta property="article:section" content="insights">
    <meta property="article:published_time" content="2025-06-08T16:03:25+00:00">
    <meta property="article:modified_time" content="2025-06-08T16:03:25+00:00">
    <meta property="article:tag" content="AI">
    <meta property="article:tag" content="Technology">

  <meta itemprop="name" content="瑞德·霍夫曼为AI癌症研究初创公司募资2460万美元">
  <meta itemprop="description" content="瑞德·霍夫曼为AI癌症研究初创公司募资2460万美元">
  <meta itemprop="datePublished" content="2025-06-08T16:03:25+00:00">
  <meta itemprop="dateModified" content="2025-06-08T16:03:25+00:00">
  <meta itemprop="wordCount" content="213">
  <meta itemprop="keywords" content="AI,Technology">
  <meta name="twitter:card" content="summary">
  <meta name="twitter:title" content="瑞德·霍夫曼为AI癌症研究初创公司募资2460万美元">
  <meta name="twitter:description" content="瑞德·霍夫曼为AI癌症研究初创公司募资2460万美元">

	
  </head><body class="ma0 avenir bg-near-white development">

    
  
  

  <header>
    <div class="bg-black">
      <nav class="pv3 ph3 ph4-ns" role="navigation">
  <div class="flex-l center items-center justify-between">
    <a href="/" class="f3 fw2 hover-white white-90 dib no-underline">
      
        <img src="/logo/logo.png" class="w100 mw5-ns" alt="AI内参" />
      
    </a>
    <div class="flex-l items-center">
      

      
        <ul class="pl0 mr3">
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white white-90 no-underline" href="/" title="">
              首页
            </a>
          </li>
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white white-90 no-underline" href="/insights/" title="">
              洞察
            </a>
          </li>
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white white-90 no-underline" href="/morningnews/" title="">
              早报
            </a>
          </li>
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white white-90 no-underline" href="/newspaper/" title="">
              日报
            </a>
          </li>
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white white-90 no-underline" href="/explore/" title="">
              主题探索
            </a>
          </li>
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white white-90 no-underline" href="/about/" title="">
              关于
            </a>
          </li>
          
        </ul>
      
      <div class="ananke-socials"></div>

    </div>
  </div>
</nav>

    </div>
  </header>



    <main class="pb7" role="main">
      
  
  
  <article class="flex-l mw8 center ph3 flex-wrap justify-between">
    <header class="mt4 w-100">
      <aside class="instapaper_ignoref helvetica tracked">
        <span style="color: #999;">2025-06-08 16:03</span>
      </aside><div id="sharing" class="mt3 ananke-socials"><a href="https://twitter.com/intent/tweet/?text=%E7%91%9E%E5%BE%B7%C2%B7%E9%9C%8D%E5%A4%AB%E6%9B%BC%E4%B8%BAAI%E7%99%8C%E7%97%87%E7%A0%94%E7%A9%B6%E5%88%9D%E5%88%9B%E5%85%AC%E5%8F%B8%E5%8B%9F%E8%B5%842460%E4%B8%87%E7%BE%8E%E5%85%83%20-%20%E7%91%9E%E5%BE%B7%C2%B7%E9%9C%8D%E5%A4%AB%E6%9B%BC%E4%B8%BAAI%E7%99%8C%E7%97%87%E7%A0%94%E7%A9%B6%E5%88%9D%E5%88%9B%E5%85%AC%E5%8F%B8%E5%8B%9F%E8%B5%842460%E4%B8%87%E7%BE%8E%E5%85%83&amp;amp;url=http%3A%2F%2Flocalhost%3A1315%2Finsights%2F2025-06-08-article-416%2F"
          class="ananke-social-link x-twitter no-underline"
          title="Share on X" aria-label="Share on X"
          target="_blank" rel="nofollow noopener noreferrer"><span class="icon">
                <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 6.6.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc. --><path d="M389.2 48h70.6L305.6 224.2 487 464H345L233.7 318.6 106.5 464H35.8L200.7 275.5 26.8 48H172.4L272.9 180.9 389.2 48zM364.4 421.8h39.1L151.1 88h-42L364.4 421.8z"/></svg>
                
              </span></a><a href="http://service.weibo.com/share/share.php?title=%E7%91%9E%E5%BE%B7%C2%B7%E9%9C%8D%E5%A4%AB%E6%9B%BC%E4%B8%BAAI%E7%99%8C%E7%97%87%E7%A0%94%E7%A9%B6%E5%88%9D%E5%88%9B%E5%85%AC%E5%8F%B8%E5%8B%9F%E8%B5%842460%E4%B8%87%E7%BE%8E%E5%85%83%20-%20%E7%91%9E%E5%BE%B7%C2%B7%E9%9C%8D%E5%A4%AB%E6%9B%BC%E4%B8%BAAI%E7%99%8C%E7%97%87%E7%A0%94%E7%A9%B6%E5%88%9D%E5%88%9B%E5%85%AC%E5%8F%B8%E5%8B%9F%E8%B5%842460%E4%B8%87%E7%BE%8E%E5%85%83&amp;amp;url=http%3A%2F%2Flocalhost%3A1315%2Finsights%2F2025-06-08-article-416%2F"
          class="ananke-social-link weibo no-underline"
          title="Share on Weibo" aria-label="Share on Weibo"
          target="_blank" rel="nofollow noopener noreferrer"><span class="icon">
                <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 6.6.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc. --><path d="M407 177.6c7.6-24-13.4-46.8-37.4-41.7-22 4.8-28.8-28.1-7.1-32.8 50.1-10.9 92.3 37.1 76.5 84.8-6.8 21.2-38.8 10.8-32-10.3zM214.8 446.7C108.5 446.7 0 395.3 0 310.4c0-44.3 28-95.4 76.3-143.7C176 67 279.5 65.8 249.9 161c-4 13.1 12.3 5.7 12.3 6 79.5-33.6 140.5-16.8 114 51.4-3.7 9.4 1.1 10.9 8.3 13.1 135.7 42.3 34.8 215.2-169.7 215.2zm143.7-146.3c-5.4-55.7-78.5-94-163.4-85.7-84.8 8.6-148.8 60.3-143.4 116s78.5 94 163.4 85.7c84.8-8.6 148.8-60.3 143.4-116zM347.9 35.1c-25.9 5.6-16.8 43.7 8.3 38.3 72.3-15.2 134.8 52.8 111.7 124-7.4 24.2 29.1 37 37.4 12 31.9-99.8-55.1-195.9-157.4-174.3zm-78.5 311c-17.1 38.8-66.8 60-109.1 46.3-40.8-13.1-58-53.4-40.3-89.7 17.7-35.4 63.1-55.4 103.4-45.1 42 10.8 63.1 50.2 46 88.5zm-86.3-30c-12.9-5.4-30 .3-38 12.9-8.3 12.9-4.3 28 8.6 34 13.1 6 30.8.3 39.1-12.9 8-13.1 3.7-28.3-9.7-34zm32.6-13.4c-5.1-1.7-11.4.6-14.3 5.4-2.9 5.1-1.4 10.6 3.7 12.9 5.1 2 11.7-.3 14.6-5.4 2.8-5.2 1.1-10.9-4-12.9z"/></svg>
                
              </span></a><a href="javascript:void(0)" onclick="showWeixinQR()"
          class="ananke-social-link weixin no-underline"
          title="Share on Weixin" aria-label="Share on Weixin"><span class="icon">
                <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 576 512"><!--! Font Awesome Free 6.6.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc. --><path d="M385.2 167.6c6.4 0 12.6.3 18.8 1.1C387.4 90.3 303.3 32 207.7 32 100.5 32 13 104.8 13 197.4c0 53.4 29.3 97.5 77.9 131.6l-19.3 58.6 68-34.1c24.4 4.8 43.8 9.7 68.2 9.7 6.2 0 12.1-.3 18.3-.8-4-12.9-6.2-26.6-6.2-40.8-.1-84.9 72.9-154 165.3-154zm-104.5-52.9c14.5 0 24.2 9.7 24.2 24.4 0 14.5-9.7 24.2-24.2 24.2-14.8 0-29.3-9.7-29.3-24.2.1-14.7 14.6-24.4 29.3-24.4zm-136.4 48.6c-14.5 0-29.3-9.7-29.3-24.2 0-14.8 14.8-24.4 29.3-24.4 14.8 0 24.4 9.7 24.4 24.4 0 14.6-9.6 24.2-24.4 24.2zM563 319.4c0-77.9-77.9-141.3-165.4-141.3-92.7 0-165.4 63.4-165.4 141.3S305 460.7 397.6 460.7c19.3 0 38.9-5.1 58.6-9.9l53.4 29.3-14.8-48.6C534 402.1 563 363.2 563 319.4zm-219.1-24.5c-9.7 0-19.3-9.7-19.3-19.6 0-9.7 9.7-19.3 19.3-19.3 14.8 0 24.4 9.7 24.4 19.3 0 10-9.7 19.6-24.4 19.6zm107.1 0c-9.7 0-19.3-9.7-19.3-19.6 0-9.7 9.7-19.3 19.3-19.3 14.5 0 24.4 9.7 24.4 19.3.1 10-9.9 19.6-24.4 19.6z"/></svg>
                
              </span></a></div><h1 class="f1 athelas mt3 mb1">瑞德·霍夫曼为AI癌症研究初创公司募资2460万美元</h1>
      
      <p class="tracked"><strong>AI News Assistant</strong>
      </p>
      
      
    </header>
    <div class="article-content nested-copy-line-height lh-copy serif f4 nested-links mid-gray pr4-l w-two-thirds-l"><h2 id="content">Content</h2>
<article>
## 领英联合创始人里德·霍夫曼为 AI 癌症研究初创公司 Manas AI 筹集 2460 万美元
<p><strong>TL;DR</strong> 领英联合创始人里德·霍夫曼与著名癌症研究员悉达多·穆克吉共同创立了 Manas AI，一家专注于利用人工智能加速癌症药物发现的初创公司，并已成功筹集 2460 万美元资金。</p>
<h3 id="革新癌症治疗manas-ai-获-2460-万美元启动资金">革新癌症治疗：Manas AI 获 2460 万美元启动资金</h3>
<p>知名科技投资者和领英联合创始人里德·霍夫曼（Reid Hoffman）正在进军人工智能驱动的癌症研究领域，他与《众病之王：癌症传》（The Emperor of All Maladies）的作者、著名癌症研究员悉达多·穆克吉（Siddhartha Mukherjee）共同创立了 Manas AI。这家新公司已成功筹集 2460 万美元的启动资金，旨在利用人工智能的力量彻底改变癌症药物的发现过程 <sup id="fnref:1"><a href="#fn:1" class="footnote-ref" role="doc-noteref">1</a></sup>, <sup id="fnref:2"><a href="#fn:2" class="footnote-ref" role="doc-noteref">2</a></sup>。</p>
<p>Manas AI 的核心使命是显著缩短药物发现的时间，将其从通常长达十年的过程缩短至短短几年，从而更快地将挽救生命的治疗方案带给患者 <sup id="fnref:3"><a href="#fn:3" class="footnote-ref" role="doc-noteref">3</a></sup>。</p>
<h3 id="manas-ai-的愿景与方法">Manas AI 的愿景与方法</h3>
<p>Manas AI 的创立标志着人工智能在生物技术领域应用的又一重要里程碑。这家初创公司将专注于开发用于癌症治疗的精确设计分子。其方法包括利用人工智能设计新分子，然后在湿实验室中进行测试 <sup id="fnref:4"><a href="#fn:4" class="footnote-ref" role="doc-noteref">4</a></sup>。</p>
<p>尽管 Manas AI 获得的 2460 万美元资金与其他一些人工智能生物技术初创公司相比规模适中，但该公司抱负远大，力求在人工智能驱动的医学领域产生重大影响 <sup id="fnref1:3"><a href="#fn:3" class="footnote-ref" role="doc-noteref">3</a></sup>。据霍夫曼在 LinkedIn 上表示，Manas AI 的目标是“将药物发现从一个长达十年的过程转变为只需几年，让患者更快地获得挽救生命的治疗” <sup id="fnref2:3"><a href="#fn:3" class="footnote-ref" role="doc-noteref">3</a></sup>。</p>
<p>为了实现这一目标，Manas AI 还将利用微软的云计算平台 Azure，并借助微软在人工智能领域的深厚专业知识来开发新型药物 <sup id="fnref1:4"><a href="#fn:4" class="footnote-ref" role="doc-noteref">4</a></sup>。</p>
<h3 id="关键人物与战略合作">关键人物与战略合作</h3>
<p>Manas AI 由两位具有深远影响力的人物共同创立：</p>
<ul>
<li><strong>里德·霍夫曼（Reid Hoffman）</strong>：作为领英的联合创始人，霍夫曼在科技投资领域享誉盛名，他的参与为 Manas AI 带来了强大的技术背景和战略洞察力 <sup id="fnref1:1"><a href="#fn:1" class="footnote-ref" role="doc-noteref">1</a></sup>。除了霍夫曼本人，本轮种子轮融资的主要投资者还包括 General Catalyst 和 Greylock Partners <sup id="fnref3:3"><a href="#fn:3" class="footnote-ref" role="doc-noteref">3</a></sup>。</li>
<li><strong>悉达多·穆克吉（Siddhartha Mukherjee）</strong>：他是一位杰出的癌症研究员，也是普利策奖获奖作品《众病之王：癌症传》的作者。穆克吉的科学专长和对癌症复杂性的深刻理解是 Manas AI 研发努力不可或缺的一部分 <sup id="fnref2:1"><a href="#fn:1" class="footnote-ref" role="doc-noteref">1</a></sup>。</li>
</ul>
<p>这项合作汇聚了顶尖的科技创业经验和深厚的医学科学知识，为 Manas AI 在攻克癌症这一艰巨任务中奠定了坚实的基础。</p>
<h3 id="展望未来加速癌症治疗的希望">展望未来：加速癌症治疗的希望</h3>
<p>Manas AI 的启动和其所筹集到的资金，凸显了人工智能在加速医疗发现方面日益增长的潜力，特别是在癌症等复杂疾病领域。通过结合先进的 AI 技术和严谨的湿实验室测试，Manas AI 有望大幅提高药物研发的效率和速度。</p>
<p>如果 Manas AI 能够实现其雄心勃勃的目标，将药物发现过程从十年缩短到几年，那么它将不仅为癌症患者带来更快的治疗选择，也将对整个制药行业产生深远的影响，推动精准医疗和个性化治疗的进步。这一举措预示着医疗领域未来将更多地依赖交叉学科的创新合作，以应对全球最紧迫的健康挑战。</p>
<h2 id="references">References</h2>
</article>
<p><strong>主要关键词或标签</strong>: 里德·霍夫曼, Manas AI, 癌症研究, 人工智能, 药物发现, 悉达多·穆克吉, 生物技术, 医疗创新</p>
<h2 id="tags">Tags</h2>
<p>#AI #Technology</p>
<hr>
<p><em>This article was automatically generated by AI News Assistant on 6/9/2025, 12:03:25 AM</em></p>
<div class="footnotes" role="doc-endnotes">
<hr>
<ol>
<li id="fn:1">
<p>Wall Street Journal (Current Date). &quot;<a href="https://www.wsj.com/tech/ai/manas-ai-drug-discovery-reid-hoffman-93a6c023">Reid Hoffman Raises $24.6 Million for AI Cancer-Research Startup</a>&quot;. The Wall Street Journal. Retrieved January 27, 2025.&#160;<a href="#fnref:1" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a>&#160;<a href="#fnref1:1" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a>&#160;<a href="#fnref2:1" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:2">
<p>MSN (Current Date). &quot;<a href="https://www.msn.com/en-us/money/technology/reid-hoffman-raises-246-million-for-ai-cancer-research-startup/ar-AA1xW0Q3">Reid Hoffman Raises $24.6 Million for AI Cancer Research Startup - MSN</a>&quot;. MSN. Retrieved January 27, 2025.&#160;<a href="#fnref:2" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:3">
<p>Analytics India Magazine (Current Date). &quot;<a href="https://analyticsindiamag.com/ai-news-updates/reid-hoffmans-manas-ai-raises-24-6-million/">Reid Hoffman's Manas AI Raises $24.6 Million - Analytics India Magazine</a>&quot;. Analytics India Magazine. Retrieved January 27, 2025.&#160;<a href="#fnref:3" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a>&#160;<a href="#fnref1:3" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a>&#160;<a href="#fnref2:3" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a>&#160;<a href="#fnref3:3" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:4">
<p>TechCrunch (Current Date). &quot;<a href="https://techcrunch.com/2025/01/27/reid-hoffmans-manas-ai-raises-24-6m-a-fraction-of-other-ai-drug-discovery-startups/">Reid Hoffman’s Manas AI raises $24.6M, a fraction of other AI drug ...</a>&quot;. TechCrunch. Retrieved January 27, 2025.&#160;<a href="#fnref:4" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a>&#160;<a href="#fnref1:4" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
</ol>
</div>
<ul class="pa0">
  
   <li class="list di">
     <a href="/tags/ai/" class="link f5 grow br-pill ba ph3 pv2 mb2 dib black sans-serif no-underline">AI</a>
   </li>
  
   <li class="list di">
     <a href="/tags/technology/" class="link f5 grow br-pill ba ph3 pv2 mb2 dib black sans-serif no-underline">Technology</a>
   </li>
  
</ul>
<div class="mt6 instapaper_ignoref">
      
      
      </div>
    </div>

    <aside class="w-30-l mt6-l">




  <div class="bg-light-gray pa3 nested-list-reset nested-copy-line-height nested-links">
    <p class="f5 b mb3" style="color: #666;">相关阅读</p>
    <ul class="pa0 list">
	   
	     <li  class="mb2">
          <a href="/insights/2025-06-08-article-415/">硅谷热捧中国产AI模型</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/insights/2025-06-08-article-414/">科技媒体电信要闻：市场热议</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/insights/2025-06-08-article-413/">中国DeepSeek AI：要点解析</a>
        </li>
	    
    </ul>
</div>



<div class="bg-light-gray pa3 nested-list-reset nested-copy-line-height nested-links mt3">
  <p class="f5 b mb3" style="color: #666;">AI写作声明</p>
  <div class="f6 lh-copy" style="color: #777;">
    <p>本文由AI系统全流程生成，涵盖选题、资料整合与撰写。文章发布后由人工编辑进行核查。文末附有详细的[引用信息索引]，供您查证溯源。</p>
  </div>
</div></aside>

  </article>

    </main>
    <footer class="bg-black bottom-0 w-100 pa3" role="contentinfo">
  <div class="flex justify-between">
  <a class="f4 fw4 hover-white white-70 dn dib-ns pv2 ph3 no-underline" href="http://localhost:1315/" >
    &copy;  AI内参 2025 
  </a>
    <div><div class="ananke-socials"></div>
</div>
  </div>
</footer>

    <script src="/js/relative-time.js"></script>
  </body>
</html>
